SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CytomX to Receive $5 Million Regeneron Collaboration Milestone

CytomX Therapeutics said it will receive a $5 million preclinical milestone payment under its collaboration with Regeneron.

CTMX

Story updates

09:16:42 PM UTC
SquawkNews
CytomX to receive $5 million preclinical milestone payment -- The CytomX and Regeneron collaboration began in 2022 and was expanded in June 2026 -EMERYVILLE, Calif., Nov. 17, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. NASDAQ:CTMX, a leader in the field of masked, conditionally activated b…

Related stories